Celldex Therapeutics shares owned by Mirae Asset Global Etfs Holdings
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Mirae Asset Global Etfs Holdings
from 13F filings
Historical chart of Mirae Asset Global Etfs Holdings investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Mirae Asset Global Etfs Holdings consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by Mirae Asset Global Etfs Holdings
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $916k | 35k | 25.87 |
| 2025-06-30 | $802k | 39k | 20.35 |
| 2025-03-31 | $866k | 44k | 19.93 |
| 2024-12-31 | $1.1M | 43k | 25.12 |
| 2024-09-30 | $1.3M | 39k | 33.20 |
| 2024-06-30 | $1.3M | 35k | 37.01 |
More positions owned by Mirae Asset Global Etfs Holdings
View all positions for Mirae Asset Global Etfs Holdings